{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Painful+Diabetic+Peripheral+Neuropathy&page=2", "query": { "condition": "Painful Diabetic Peripheral Neuropathy", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Painful+Diabetic+Peripheral+Neuropathy&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-26T11:58:42.733Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02643251", "title": "The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Painful Diabetic Neuropathy", "Diabetic Neuropathy", "Neuropathy" ], "interventions": [ { "name": "Clonidine Hydrochloride Topical Gel, 0.1%", "type": "DRUG" }, { "name": "Clonidine Hydrochloride Gel Comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioDelivery Sciences International", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 138, "start_date": "2015-12", "completion_date": "2016-11", "has_results": true, "last_update_posted_date": "2017-09-20", "last_synced_at": "2026-06-26T11:58:42.733Z", "location_count": 25, "location_summary": "Glendale, Arizona • Phoenix, Arizona • Anaheim, California + 20 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Norco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02643251" }, { "nct_id": "NCT00643760", "title": "A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Neuropathy, Diabetic" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "GEn 1200mg/day", "type": "DRUG" }, { "name": "GEn 2400mg/day", "type": "DRUG" }, { "name": "GEn 3600mg/day", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "XenoPort, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 421, "start_date": "2008-03", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2013-07-22", "last_synced_at": "2026-06-26T11:58:42.733Z", "location_count": 90, "location_summary": "Alabaster, Alabama • Birmingham, Alabama • Dothan, Alabama + 81 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Hoover", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00643760" }, { "nct_id": "NCT00348894", "title": "[S,S]-Reboxetine Long Term Safety Study In Chronic Painful Diabetic Peripheral Neuropathy.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pain" ], "interventions": [ { "name": "[S,S]-Reboxetine", "type": "DRUG" }, { "name": "Any", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 136, "start_date": "2006-07", "completion_date": "2007-10", "has_results": false, "last_update_posted_date": "2011-06-01", "last_synced_at": "2026-06-26T11:58:42.733Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 20 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00348894" }, { "nct_id": "NCT05838755", "title": "A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pain" ], "interventions": [ { "name": "GSK3858279", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 147, "start_date": "2023-09-20", "completion_date": "2025-02-17", "has_results": true, "last_update_posted_date": "2025-11-21", "last_synced_at": "2026-06-26T11:58:42.733Z", "location_count": 19, "location_summary": "Anniston, Alabama • Surprise, Arizona • Cerritos, California + 15 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Surprise", "state": "Arizona" }, { "city": "Cerritos", "state": "California" }, { "city": "Lomita", "state": "California" }, { "city": "Largo", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05838755" }, { "nct_id": "NCT01822925", "title": "Study of DA-9801 to Treat Diabetic Neuropathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Neuropathy" ], "interventions": [ { "name": "DA-9801 300mg", "type": "DRUG" }, { "name": "DA-9801 600mg", "type": "DRUG" }, { "name": "DA-9801 900mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NeuroBo Pharmaceuticals Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 128, "start_date": "2013-11", "completion_date": "2015-01", "has_results": true, "last_update_posted_date": "2020-03-20", "last_synced_at": "2026-06-26T11:58:42.733Z", "location_count": 14, "location_summary": "Lakewood, California • Walnut Creek, California • Milford, Connecticut + 10 more", "locations": [ { "city": "Lakewood", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Milford", "state": "Connecticut" }, { "city": "Brandon", "state": "Florida" }, { "city": "West Palm Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01822925" }, { "nct_id": "NCT01743976", "title": "Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Neuropathic Pain" ], "interventions": [ { "name": "Donepezil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wake Forest University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 5, "start_date": "2012-12", "completion_date": "2013-10-23", "has_results": true, "last_update_posted_date": "2021-03-02", "last_synced_at": "2026-06-26T11:58:42.733Z", "location_count": 2, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01743976" }, { "nct_id": "NCT01533428", "title": "A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Peripheral Neuropathy", "Pain" ], "interventions": [ { "name": "Capsaicin 8%", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astellas Pharma Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 369, "start_date": "2012-02", "completion_date": "2014-02", "has_results": true, "last_update_posted_date": "2015-11-04", "last_synced_at": "2026-06-26T11:58:42.733Z", "location_count": 29, "location_summary": "Anniston, Alabama • Fresno, California • Long Beach, California + 24 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Fresno", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01533428" }, { "nct_id": "NCT00625833", "title": "A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Neuropathies" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "[S,S]-Reboxetine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 330, "start_date": "2007-12", "completion_date": "2008-11", "has_results": false, "last_update_posted_date": "2019-12-13", "last_synced_at": "2026-06-26T11:58:42.733Z", "location_count": 32, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Mission Viejo, California + 24 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "New Britain", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00625833" }, { "nct_id": "NCT00785577", "title": "A Study for Treatment of Pain in Patients With Diabetic Neuropathy.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Neuropathy, Painful" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "LY545694 21 mg", "type": "DRUG" }, { "name": "LY545694 49 mg", "type": "DRUG" }, { "name": "LY545694 105 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 273, "start_date": "2008-11", "completion_date": "2010-06", "has_results": true, "last_update_posted_date": "2012-05-31", "last_synced_at": "2026-06-26T11:58:42.733Z", "location_count": 8, "location_summary": "Greenbrae, California • Tustin, California • DeLand, Florida + 5 more", "locations": [ { "city": "Greenbrae", "state": "California" }, { "city": "Tustin", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "Fort Myers", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00785577" }, { "nct_id": "NCT06568042", "title": "Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Neuropathic Pain", "Distal Sensory Polyneuropathy" ], "interventions": [ { "name": "LY3848575", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 558, "start_date": "2024-08-22", "completion_date": "2026-09", "has_results": false, "last_update_posted_date": "2026-04-29", "last_synced_at": "2026-06-26T11:58:42.733Z", "location_count": 24, "location_summary": "Chandler, Arizona • Phoenix, Arizona • Fresno, California + 20 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Largo", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06568042" } ] }